These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 30267014)

  • 1. State-dependent effects of the D
    Sonnenschein SF; Gill KM; Grace AA
    Neuropsychopharmacology; 2019 Feb; 44(3):572-580. PubMed ID: 30267014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo actions of aripiprazole on serotonergic and dopaminergic systems in rodent brain.
    Bortolozzi A; Díaz-Mataix L; Toth M; Celada P; Artigas F
    Psychopharmacology (Berl); 2007 Apr; 191(3):745-58. PubMed ID: 17265076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insights on current and novel antipsychotic mechanisms from the MAM model of schizophrenia.
    Sonnenschein SF; Grace AA
    Neuropharmacology; 2020 Feb; 163():107632. PubMed ID: 31077730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prior antipsychotic drug treatment prevents response to novel antipsychotic agent in the methylazoxymethanol acetate model of schizophrenia.
    Gill KM; Cook JM; Poe MM; Grace AA
    Schizophr Bull; 2014 Mar; 40(2):341-50. PubMed ID: 24464874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antipsychotic drugs rapidly induce dopamine neuron depolarization block in a developmental rat model of schizophrenia.
    Valenti O; Cifelli P; Gill KM; Grace AA
    J Neurosci; 2011 Aug; 31(34):12330-8. PubMed ID: 21865475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antipsychotic drug-induced increases in ventral tegmental area dopamine neuron population activity via activation of the nucleus accumbens-ventral pallidum pathway.
    Valenti O; Grace AA
    Int J Neuropsychopharmacol; 2010 Aug; 13(7):845-60. PubMed ID: 19751544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bifeprunox and aripiprazole suppress in vivo VTA dopaminergic neuronal activity via D2 and not D3 dopamine autoreceptor activation.
    Etievant A; Bétry C; Arnt J; Haddjeri N
    Neurosci Lett; 2009 Aug; 460(1):82-6. PubMed ID: 19450663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Partial agonist properties of the antipsychotics SSR181507, aripiprazole and bifeprunox at dopamine D2 receptors: G protein activation and prolactin release.
    Cosi C; Carilla-Durand E; Assié MB; Ormiere AM; Maraval M; Leduc N; Newman-Tancredi A
    Eur J Pharmacol; 2006 Mar; 535(1-3):135-44. PubMed ID: 16554049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of repeated and acute aripiprazole or haloperidol treatment on dopamine synthesis in the dorsal striatum of young rats: comparison to adult rats.
    Der-Ghazarian T; Charntikov S; Varela FA; Crawford CA; McDougall SA
    J Neural Transm (Vienna); 2010 May; 117(5):573-83. PubMed ID: 20372943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired contextual fear-conditioning in MAM rodent model of schizophrenia.
    Gill KM; Miller SA; Grace AA
    Schizophr Res; 2018 May; 195():343-352. PubMed ID: 28927551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aberrant dopamine D2-like receptor function in a rodent model of schizophrenia.
    Perez SM; Lodge DJ
    J Pharmacol Exp Ther; 2012 Nov; 343(2):288-95. PubMed ID: 22859862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of acute and repeated administration of amisulpride, a dopamine D2/D3 receptor antagonist, on the electrical activity of midbrain dopaminergic neurons.
    Di Giovanni G; Di Mascio M; Di Matteo V; Esposito E
    J Pharmacol Exp Ther; 1998 Oct; 287(1):51-7. PubMed ID: 9765321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. α7 Nicotinic receptor-modulating agents reverse the hyperdopaminergic tone in the MAM model of schizophrenia.
    Neves GA; Grace AA
    Neuropsychopharmacology; 2018 Jul; 43(8):1712-1720. PubMed ID: 29695783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Agonist and antagonist effects of aripiprazole on D₂-like receptors controlling rat brain dopamine synthesis depend on the dopaminergic tone.
    Ma GF; Raivio N; Sabrià J; Ortiz J
    Int J Neuropsychopharmacol; 2014 Oct; 18(4):. PubMed ID: 25522390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of bifeprunox and aripiprazole on rat serotonin and dopamine neuronal activity and anxiolytic behaviour.
    Dahan L; Husum H; Mnie-Filali O; Arnt J; Hertel P; Haddjeri N
    J Psychopharmacol; 2009 Mar; 23(2):177-89. PubMed ID: 18515444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of acute and chronic administration of the selective 5-HT2C receptor antagonist SB-243213 on midbrain dopamine neurons in the rat: an in vivo extracellular single cell study.
    Blackburn TP; Minabe Y; Middlemiss DN; Shirayama Y; Hashimoto K; Ashby CR
    Synapse; 2002 Dec; 46(3):129-39. PubMed ID: 12325040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discriminative stimulus properties of S32504, a novel D3/D2 receptor agonist and antiparkinson agent, in rats: attenuation by the antipsychotics, aripiprazole, bifeprunox, N-desmethylclozapine, and by selective antagonists at dopamine D2 but not D3 receptors.
    Millan MJ; Iob L; Péglion JL; Dekeyne A
    Psychopharmacology (Berl); 2007 Apr; 191(3):767-82. PubMed ID: 17047933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Actions of novel antipsychotic agents on apomorphine-induced PPI disruption: influence of combined serotonin 5-HT1A receptor activation and dopamine D2 receptor blockade.
    Auclair AL; Kleven MS; Besnard J; Depoortère R; Newman-Tancredi A
    Neuropsychopharmacology; 2006 Sep; 31(9):1900-9. PubMed ID: 16421514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of pubertal cannabinoid administration on attentional set-shifting and dopaminergic hyper-responsivity in a developmental disruption model of schizophrenia.
    Gomes FV; Guimarães FS; Grace AA
    Int J Neuropsychopharmacol; 2014 Dec; 18(2):. PubMed ID: 25522381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered activity of midbrain dopamine neurons following 7-day withdrawal from chronic cocaine abuse is normalized by D2 receptor stimulation during the early withdrawal phase.
    Lee TH; Gao WY; Davidson C; Ellinwood EH
    Neuropsychopharmacology; 1999 Jul; 21(1):127-36. PubMed ID: 10379527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.